Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Treasury Shares (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Treasury Shares for 3 consecutive years, with $5.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares changed 0.0% year-over-year to $5.3 million, compared with a TTM value of $5.3 million through Sep 2025, changed 0.0%, and an annual FY2024 reading of $5.3 million, changed 0.0% over the prior year.
  • Treasury Shares was $5.3 million for Q3 2025 at Xenetic Biosciences, roughly flat from $5.3 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $5.3 million in Q1 2023 and bottomed at $5.3 million in Q1 2023.
  • Average Treasury Shares over 3 years is $5.3 million, with a median of $5.3 million recorded in 2023.
  • Peak annual rise in Treasury Shares hit 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Treasury Shares stood at $5.3 million in 2023, then changed by 0.0% to $5.3 million in 2024, then changed by 0.0% to $5.3 million in 2025.
  • Business Quant data shows Treasury Shares for XBIO at $5.3 million in Q3 2025, $5.3 million in Q2 2025, and $5.3 million in Q1 2025.